Analysts Project Deeper Q1 Loss for Lifeward, EPS Estimate at -$1.18
LFWD sits 49% above its 52-week low of $4.14.
Summary
Lifeward Ltd. (LFWD) is facing a challenging Q1'26 outlook, with analysts projecting an EPS loss of $1.18 and revenue of $5.78 million, ahead of its official earnings release tomorrow. This estimated EPS loss is deeper than the prior quarter's estimate of $0.96, and the revenue estimate also marks a sequential decline. This news is particularly significant given the company's recent "going concern" warning in its last 10-K and its reliance on highly dilutive financing. The worsening analyst expectations for both top and bottom lines could further pressure the stock. Traders will be keenly watching the actual Q1'26 results and management's forward guidance for any further indications of the company's financial trajectory.
At the time of this announcement, LFWD was trading at $6.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.1M. The 52-week trading range was $4.14 to $17.76. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.